Telesis Bio Inc.

NASDAQ: TBIO
$0.32
+$0.01 (+2.6%)
Closing price April 23, 2024
Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutic company, develops drugs to treat diseases caused by protein or gene dysfunction. The company is headquartered in Lexington, Massachusetts.

Top Analyst Upgrades and Downgrades: Agilent, Carnival, Clorox, Darden, Pinduoduo, QuantumScape, Shell, Williams-Sonoma and More
Thursday's top analyst upgrades and downgrades included Agilent Technologies, Carnival, Clorox, Darden Restaurants, Pinduoduo, QuantumScape, Royal Dutch Shell and Williams-Sonoma.
Lee Jackson
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: Amex, AT&T, CRISPR, DocuSign, ONEOK, Regeneron, Shopify, Tesla and More
Monday's top analyst upgrades and downgrades included American Express, AT&T, CRISPR Therapeutics, DocuSign, ONEOK, Regeneron Pharmaceuticals, Shopify and Tesla.
Jon C. Ogg
Published:

Why the Sanofi and Translate Bio Vaccine Pact Is Win-Win
Sanofi and Translate Bio are making waves in the fight against the novel coronavirus as the two have agreed to expand their existing 2018 collaboration and license agreement
Chris Lange
Published: